Certain proteoglycans, such as syndecan-1 and glypican-1, promote tumor growth and dissemination by enhancing growth factor signaling and cell migration, whereas others, including decorin and lumican, inhibit tumor progression by modulating immune responses and collagen fibrillogenesis. This evidence concerns the gene GPC1 and neoplasm.